<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87480">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02085551</url>
  </required_header>
  <id_info>
    <org_study_id>CLP 7051</org_study_id>
    <nct_id>NCT02085551</nct_id>
  </id_info>
  <brief_title>Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery</brief_title>
  <acronym>PRISM</acronym>
  <official_title>The Prism Trial: A Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penumbra Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Penumbra Inc.</source>
  <oversight_info>
    <authority>US:Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this retrospective case review study is to determine the safety and
      effectiveness of the Penumbra and Indigo Systems for mechanical thrombectomy in a cohort of
      patients with confirmed peripheral or visceral arterial occlusion or embolus. This is a
      retrospective, single arm, multi-center trial. Up to 100 patients at up to 10 centers will
      be enrolled. Angiographic assessment of vessel patency at immediate post-procedure as
      measured by TIMI scores and procedural serious adverse events are assessed and recorded.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Angiographic assessment of vessel patency at immediate post-procedure as measured by TIMI scores</measure>
    <time_frame>Immediate post-procedure</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Procedural serious adverse events</measure>
    <time_frame>During the procedure</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Peripheral Arterial Occlusion or Emboli</condition>
  <arm_group>
    <arm_group_label>Mechanical thrombectomy by the Indigo System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mechanical Thrombectomy by the Indigo System</intervention_name>
    <arm_group_label>Mechanical thrombectomy by the Indigo System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Evidence of a peripheral or visceral arterial occlusion or embolus (TIMI 0-1) prior
             to treatment.

          -  Treatment with components of the Penumbra and/or Indigo System.

        Exclusion Criteria:

          -  Participation in another clinical investigation that may confound the results of the
             study.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Saxon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tri-City Medical Center, San Diego, CA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Corey Teigen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanford Medical Center Fargo, ND</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeff Wayland, BS</last_name>
    <phone>510-995-2141</phone>
    <email>jwayland@penumbrainc.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Siu P Sit, PhD</last_name>
    <phone>510 748 3200</phone>
    <email>siupo.sit@penumbrainc.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tri-City Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Saxon, MD</last_name>
      <phone>760-940-4055</phone>
      <email>rsaxon5@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Lauurie Stewart</last_name>
      <phone>760-940-7166</phone>
      <email>laurie.stewart@sandiegoimaging.com</email>
    </contact_backup>
    <investigator>
      <last_name>Richard Saxon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baptist Health South Florida</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Benenati, MD</last_name>
      <email>jamesb@baptisthealth.net</email>
    </contact>
    <investigator>
      <last_name>James Benenati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bulent Arslan</last_name>
      <email>BULENT_ARSLAN@rush.edu</email>
    </contact>
    <investigator>
      <last_name>Bulent Arslan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Arko, MD</last_name>
      <email>farkomd@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Frank Arko, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford Medical Center</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amber Leach</last_name>
      <phone>701-234-5899</phone>
      <email>amber.leach@sanfordhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Wurgler</last_name>
      <phone>701-234-6233</phone>
      <email>jennifer.wurgler@sanfordhealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Corey Teigen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 1, 2014</lastchanged_date>
  <firstreceived_date>March 5, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>peripheral arterial occlusion</keyword>
  <keyword>visceral emboli</keyword>
  <keyword>limb ischemia</keyword>
  <keyword>adverse events</keyword>
  <keyword>Indigo System</keyword>
  <keyword>aspiration</keyword>
  <keyword>mechanical thrombectomy</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arterial Occlusive Diseases</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
